Versant Venture Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,205,407
Closed -$31.2M 12
2020
Q2
$31.2M Hold
1,205,407
4.49% 6
2020
Q1
$29.3M Hold
1,205,407
8.04% 4
2019
Q4
$33.7M Hold
1,205,407
10.14% 2
2019
Q3
$28.9M Sell
1,205,407
-1,205,408
-50% -$32.1M 11.19% 2
2019
Q2
$68.7M Sell
2,410,815
-1,205,406
-33% -$30.1M 20.03% 2
2019
Q1
$90.5M Hold
3,616,221
29.8% 2
2018
Q4
$45.5M Hold
3,616,221
22.52% 2
2018
Q3
$34.5M Buy
+3,616,221
New +$39.9M 11.75% 3

Other funds holding VCYT

Versant Venture Management's VCYT Position: Q3 2020 in Review

Versant Venture Management sold out of Veracyte (VCYT) in Q3 2020, closing a stake of 1,205,407 shares — an estimated $31.2M sold.

Versant Venture Management first reported a position in VCYT in Q3 2018 and held it in 8 quarters. The position peaked at $90.5M in Q1 2019. 189 funds tracked by Wall St. Rank hold VCYT as of Q3 2020.

  • Versant Venture Management reported no remaining Veracyte position as of Q3 2020 after selling out during the quarter.
  • Versant Venture Management sold 1,205,407 Veracyte shares in Q3 2020, an estimated $31.2M.
  • Versant Venture Management first reported a position in Veracyte in Q3 2018 and held it in 8 quarters.
  • Versant Venture Management's Veracyte position peaked at $90.5M in Q1 2019.
  • 189 funds tracked by Wall St. Rank held Veracyte as of Q3 2020.

Based on Versant Venture Management's 13F filing for Q3 2020, filed 12 Nov 2020.